Osteoporosis treatment has low adherence and persistence. This study evaluated if greater patient involvement could improve them. At 12 months, only 114 out of 344 participants were "fully adherent and persistent" (all drug doses taken throughout the study). Only frequency of drug administration had a significant influence on adherence. INTRODUCTION: Osteoporosis affects millions of individuals worldwide. There are now several effective drugs, but adherence to and persistence with treatment are low. This 12-month multicenter, prospective, randomized study evaluated the efficacy of two different methods aimed at improving adherence and persistence through greater patient involvement, compared with standard clinical practice. METHODS: Three hundred thirty-four post-menopausal women, receiving an oral prescription for osteoporosis for the first time, were recruited and randomized into three groups: group 1 (controls, managed according to standard clinical practice) and groups 2 and 3 (managed with greater patient and caregiver involvement and special reinforcements: group 2, instructed to use several different "reminders"; group 3, same "reminders" as group 2, plus regular phone calls from and meetings at the referring Center). All enrolled women had two visits (baseline and 12 months). RESULTS: Of 334 enrolled women, 247 (74 %) started the prescribed therapy. Of those who started, 219 (88.7 %) persisted in therapy for at least 10 months. At final evaluation, only 114 women were considered as "fully adherent and persistent" (all doses taken throughout the 12 months). There were no significant differences regarding "full adherence" among the three randomized groups. The frequency of drug administration had a significant influence: weekly administration had a >5-fold higher adherence and monthly administration an 8-fold higher adherence (p < 0.0001) than daily administration. CONCLUSIONS: The special effort of devising and providing additional reminders did not prove effective. Additional interventions during the follow-up, including costly interventions such as phone calls and educational meetings, did not provide significant advantages.

Improving adherence to and persistence with oral therapy of osteoporosis / Bianchi, Ml; Duca, P; Vai, S; Guglielmi, G; Viti, R; Battista, C; Scillitani, A; Muscarella, S; Luisetto, G; Camozzi, V; Nuti, R; Caffarelli, C; Gonnelli, S; Albanese, Carlina Veneranda; De Tullio, Viviana Maria; Isaia, G; D'Amelio, P; Broggi, F; Croci, M.. - In: OSTEOPOROSIS INTERNATIONAL. - ISSN 0937-941X. - STAMPA. - 26:5(2015), pp. 1629-1638. [10.1007/s00198-015-3038-9]

Improving adherence to and persistence with oral therapy of osteoporosis

ALBANESE, CARLINA VENERANDA
Membro del Collaboration Group
;
DE TULLIO, VIVIANA MARIA
Membro del Collaboration Group
;
2015

Abstract

Osteoporosis treatment has low adherence and persistence. This study evaluated if greater patient involvement could improve them. At 12 months, only 114 out of 344 participants were "fully adherent and persistent" (all drug doses taken throughout the study). Only frequency of drug administration had a significant influence on adherence. INTRODUCTION: Osteoporosis affects millions of individuals worldwide. There are now several effective drugs, but adherence to and persistence with treatment are low. This 12-month multicenter, prospective, randomized study evaluated the efficacy of two different methods aimed at improving adherence and persistence through greater patient involvement, compared with standard clinical practice. METHODS: Three hundred thirty-four post-menopausal women, receiving an oral prescription for osteoporosis for the first time, were recruited and randomized into three groups: group 1 (controls, managed according to standard clinical practice) and groups 2 and 3 (managed with greater patient and caregiver involvement and special reinforcements: group 2, instructed to use several different "reminders"; group 3, same "reminders" as group 2, plus regular phone calls from and meetings at the referring Center). All enrolled women had two visits (baseline and 12 months). RESULTS: Of 334 enrolled women, 247 (74 %) started the prescribed therapy. Of those who started, 219 (88.7 %) persisted in therapy for at least 10 months. At final evaluation, only 114 women were considered as "fully adherent and persistent" (all doses taken throughout the 12 months). There were no significant differences regarding "full adherence" among the three randomized groups. The frequency of drug administration had a significant influence: weekly administration had a >5-fold higher adherence and monthly administration an 8-fold higher adherence (p < 0.0001) than daily administration. CONCLUSIONS: The special effort of devising and providing additional reminders did not prove effective. Additional interventions during the follow-up, including costly interventions such as phone calls and educational meetings, did not provide significant advantages.
2015
adherence; oral therapy; osteoporosis; persistence; post-menopausal women
01 Pubblicazione su rivista::01a Articolo in rivista
Improving adherence to and persistence with oral therapy of osteoporosis / Bianchi, Ml; Duca, P; Vai, S; Guglielmi, G; Viti, R; Battista, C; Scillitani, A; Muscarella, S; Luisetto, G; Camozzi, V; Nuti, R; Caffarelli, C; Gonnelli, S; Albanese, Carlina Veneranda; De Tullio, Viviana Maria; Isaia, G; D'Amelio, P; Broggi, F; Croci, M.. - In: OSTEOPOROSIS INTERNATIONAL. - ISSN 0937-941X. - STAMPA. - 26:5(2015), pp. 1629-1638. [10.1007/s00198-015-3038-9]
File allegati a questo prodotto
File Dimensione Formato  
Bianchi_Osteoporosis_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 619.56 kB
Formato Adobe PDF
619.56 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/770997
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 27
social impact